Literature DB >> 23046323

The pitfalls of femoropopliteal stenting trials.

Bibombe P Mwipatayi1, Benjamin D K Leong, Joe Hockley, Vikram Vijayan.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23046323     DOI： 10.1583/JEVT-12-3898C.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN： 1526-6028            Impact factor:   3.487


× No keyword cloud information.
  2 in total

1.  A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial.

Authors:  Krishna J Rocha-Singh; Marc Bosiers; Greg Schultz; Michael R Jaff; Manish Mehta; Jon S Matsumura
Journal:  Catheter Cardiovasc Interv       Date:  2015-02-25       Impact factor: 2.692

2.  Antithrombotic therapy after femoropopliteal artery stenting: 12-month results from Japan Postmarketing Surveillance.

Authors:  Osami Kawarada; Michikazu Nakai; Kunihiro Nishimura; Hideki Miwa; Yusuke Iwasaki; Daitaro Kanno; Tatsuya Nakama; Yoshito Yamamoto; Nobuhiko Ogata; Masato Nakamura; Satoshi Yasuda
Journal:  Heart Asia       Date:  2019-03-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.